Insider · CIK 0002078374
Jason Paul Steik
Files at PNTG (Pennant Group, Inc.). First filing Aug 10, 2026, latest Aug 10, 2026.
In brief
Jason Paul Steik files SEC Form 4 as officer at PNTG (Pennant Group, Inc.). Since Aug 10, 2026, Jason Paul Steik has reported 0 open-market buys worth $0 and 1 open-market sell worth $54k, the latest filed on Aug 10, 2026.
A track record needs three past buys with six months of prices behind them; Jason Paul Steik has 0, so none is measured yet.
The newest scored trade: sold $54k of PNTG on Aug 6, 2026, filed Aug 10, 2026, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $54k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PNTG: Pennant Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Pennant Group, Inc. | $54k 1,394 shares | -8% | +75% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 6, 2026 | PNTG Pennant Group, Inc. | 1,394 0.00% of outstanding | $54k | Aug 6, 2026 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | PNTG Pennant Group, Inc. | SOpen-market sale Common Stock10b5-1 | -1,394 | $38.52 | $54k | 15,106 | Aug 10, 2026 |
| Mar 5, 2026 | PNTG Pennant Group, Inc. | AGrant or award Stock Option (right to buy)derivative | +26,000 | $33.30 | $866k | 26,000 | Mar 12, 2026 |
Questions about Jason Paul Steik
Answered from the filings on this page, as of the latest one.
Is Jason Paul Steik buying or selling?
In the last 12 months Jason Paul Steik reported 0 open-market buys worth $0 and 1 open-market sell worth $54k on SEC Form 4; the latest was sold $54k of PNTG on Aug 6, 2026. Grants, option exercises and tax withholding are not counted.
How did Jason Paul Steik's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Paul Steik has 0.
Where does Jason Paul Steik file Form 4?
Jason Paul Steik has filed Form 4 at PNTG (Pennant Group, Inc.) as Chief Clinical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.